116054 ⎘
Transferases transferring phosphorus-containing groups (2.7); Protein-serine/threonine kinases (2.7.11) Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase
METHODS AND COMPOSITIONS FOR ENHANCING ROOT SYSTEM DEVELOPMENT
#2POLYNUCLEOTIDE, PROTEIN, BIOLOGICAL MATERIAL, AND USE THEREOF IN IMPROVING QUALITY OF PLANT FRUIT
#3PLANTS GENETICALLY ENGINEERED FOR INCREASED WATER USE EFFICIENCY AND CARBON INTAKE AND METHODS FOR MAKING AND USING THEM
#4Compositions and Methods for Assessing Kinase Activity
#5COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS
#6SALT TOLERANT PLANTS
#7MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY
#8INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE
#9METHOD FOR TREATMENT OF MYOTONIC DYSTROPHY COMBINING PROTEIN EXPRESSION AND RNA INTERFERENCE VECTOR DELIVERY WITH TISSUE DETARGETING
#10MULTIPARTITE RECEPTOR AND SIGNALING COMPLEXES
#11VARIANTS OF THE HUMAN ATM PROTEIN FOR THE TREATMENT OF DISEASES RELATED TO AT LEAST ONE MUTATION OF THE ATM GENE
#12MICROORGANISMS FOR DITERPENE PRODUCTION
#13DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING MYOTONIC DYSTROPHY
#14Methods and Compositions for Inhibiting the Growth and/or proliferation of MYC-Driven Tumor Cells
#15METHOD TO PRODUCE PHOSPHORYLATED MILK PROTEINS IN MICROBES
#16METHOD OF MAKING BONE AND CARTILAGE
#17COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE-19 (COVID-19)
#18COVALENT MODIFIERS OF AKT1 AND USES THEREOF
#19HIGH-THROUGHPUT ENGINEERING OF MOLECULAR GLUES
#20COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#21SGK1 INHIBITORY COMPOSITIONS AND METHODS
#22C-RAF Mutants that Confer Resistance to RAF Inhibitors
#23COMPOSITIONS, METHODS AND SYSTEMS FOR PHOSPHORYLATION OF PROTEINS IN PLANTS
#24COMPOSITIONS AND METHODS FOR CONTROLLING CELL SIGNALING WITH CHIMERIC RECEPTORS
#25SYSTEMS AND METHODS FOR DETECTION AND QUANTIFICATION OF DOUBLE-STRANDED RNA
#26ANTISENSE TRANSFER VECTORS AND METHODS OF USE THEREOF
#27POLYPEPTIDE BASED ON RECEPTOR-INTERACTING PROTEIN KINASE-3 METHYLATION MODIFICATION AND APPLICATION THEREOF IN CELL NECROPTOSIS-RELATED DISEASES
#28MICROORGANISMS AND METHODS FOR PRODUCING REUTERIN
#29SYMRK PHOSPHORYLATION FOR ROOT NODULE ORGANOGENESIS
#30DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#31METHOD FOR PROMOTING GROWTH OF PLANTS
#32METHODS FOR MODULATING THE REGENERATIVE PHENOTYPE IN MAMMALIAN CELLS
#33GENE THERAPY VECTORS FOR USE IN PARKINSON'S DISEASE
#34ANTI-DCLK1 ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE THEREOF
#35IMMUNE CELLS ENGINEERED TO PROMOTE THANOTRANSMISSION AND USES THEREOF
#36LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
#37IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#38COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta
#39Malignant Mesothelioma Susceptibility As A Result Of Germline Leucine-Rich Repeat Kinase 2 (LRRK2) Alterations
#40MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST
#41GENETIC TOOLS USEFUL FOR IMPROVING A PLANT'S STRESS TOLERANCE
#42NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONAL POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#43USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING CANCERS
#44PREVENTION AND/OR TREATMENT OF INFLAMMATORY SKIN DISEASE
#45C-RAF mutants that confer resistance to RAF inhibitors
#46DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF
#47DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#48VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER
#49MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#50Genetically Modified T-Cells and PI3K/AKT Inhibitors For Cancer Treatment
#51TARGETING DNA-PKCS AND B7-H1 TO TREAT CANCER
#52FERMENTED MILK, MANUFACTURING METHOD THEREFOR, AND DEPHOSPHORYLATED MILK
#53Compositions and Methods for Modifying Target RNAs
#54EXPRESSION OF MODIFIED PROTEINS IN A PEROXISOME
#55INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF
#56METHODS OF CONTROLLING GRAIN SIZE AND WEIGHT
#57PROGNOSTIC BIOMARKER OF CANCER
#58DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#59The Kinase NEK10 and Its Use in Treating and Diagnosing Bronchiectasis and Other Respiratory Disorders
#60NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME
#61METHODS AND COMPOSITIONS FOR ENHANCING ROOT SYSTEM DEVELOPMENT
#62DIMERIZATION SWITCHES AND USES THEREOF
#63RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#64APPLICATION OF COMBINED INHIBITION OF LNCRNA SAMMSON AND BRAF KINASE IN DELAYING ADAPTIVE DRUG-RESISTANCE OF MELANOMA
#65Method for Predicting Therapeutic Response to Serine-Theronine Kinase Braf Inhibitor Drugs
#66PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS
#67METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS
#68Methods and Compositions for Treating Melanoma
#69Pharmaceutical Composition for Treating Muscle Disease
#70TROPANE ALKALOID (TA) PRODUCING NON-PLANT HOST CELLS, AND METHODS OF MAKING AND USING THE SAME
#71NEW INHIBITORS OF LRRK2/PP1 INTERACTION
#72RSK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES
#73NEUROPROTECTIVE GENE THERAPY TARGETING THE AKT PATHWAY
#74Compositions for treating heart disease by inhibiting the action of mAKAP-β
#75DESIGN AND OPTIMIZATION OF TYPE IV BRAF INHIBITORS FOR THE TREATMENT OF MELANOMA
#76IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#77ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION
#78PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#79Assays for detecting modified compounds
#80CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#81gRNA targeting HPK1 and a method for editing HPK1 gene
#82METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#83METHOD OF MODULATING THE ALKALOID CONTENT OF A PLANT
#84Methods and compositions for generating doubled haploid plants and use of same in breeding
#85Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
#86C-RAF mutants that confer resistance to RAF inhibitors
#87Compositions for inhibiting KRas signaling and methods of making and using same
#88Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
#89Methods for reducing LRRK2 expression
#90Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
#91COMPOSITIONS AND METHODS FOR REDUCING SPLICEOPATHY AND TREATING RNA DOMINANCE DISORDERS
#92CARDIAC REPAIR BY REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES
#93Acetate toxicity tolerance in recombinant microbial host cells
#94Protein for regulating insect resistance in and encoding gene and use thereof
#95Interfering RNA molecules
#96Composition and methods for inhibiting mammalian sterile 20-like kinase 1
#97REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#98Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#99CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM
#100METHODS AND COMPOSITIONS ENHANCING SURVIVAL AND FUNCTIONALITY OF ANTI-TUMOR AND ANTI-VIRAL T CELLS
#101Compositions for treating heart disease by inhibiting the action of mAKAPβ
#102PROCESS FOR CONTINUOUS CELL CULTURE OF GPSCS
#103Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK
#104METHODS AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
#105Mutant huntingtin-mediated protein dysfunction
#106Multipartite signaling proteins and uses thereof
#107MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#108Prevention and/or treatment of inflammatory skin disease
#109Targeting DNA-PKCS and B7-H1 to treat cancer
#110Agents and methods for treating and preventing seborrheic keratosis
#111Methods of improving mycorrhization in plants and genetically modifed plants with improved mycorrhization
#112REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#113Interfering RNA molecules
#114Protein kinase allostery sensor and methods of making and using same
#115Peptide directed protein knockdown
#116Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
#117SIGNAL TRANSDUCTION MODIFYING PROTEIN
#118NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#119Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
#120Methods and compositions for treating melanoma
#121Cell-based assay for determining mTOR activity
#122Cancer-treating pharmaceutical composition inhibiting expression of CCND3 or PAK2 gene
#123ULK1 inhibitors and methods using same
#124REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#125RNA virus vectors carrying DAI and RIPK3
#126Inhibitors of SRSF1 to treat neurodegenerative disorders
#127INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING
#128Methods of detecting DDR2 mutations
#129Assays for detecting modified compounds
#130ULK1 inhibitors and methods using same
#131C-RAF Mutants that Confer Resistance to RAF Inhibitors
#132MK2 inhibitors and uses thereof
#133Conjugates comprising RIPK2 inhibitors
#134Multipartite signaling proteins and uses thereof
#135Methods and compositions for generating doubled haploid plants and use of same in breeding
#136Antihelminthic medications for pathogenic nematodes
#137CYCLIN-DEPENDENT KINASE 5 (CDK5) INHIBITORY PEPTIDES
#138Drug delivery means
#139DIMERIZATION SWITCHES AND USES THEREOF
#140Transgenic mouse model of retinal vascular disease, method of making, and method of using
#141Interfering RNA molecules
#142Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
#143Methods for reducing LRRK2 expression
#144Composition and methods for inhibiting mammalian sterile 20-like kinase 1
#145Oncological and Neurological Therapy based on ATM, CHK2 and p53 proteins for DNA correction of transcription errors
#146INHIBITING GENE EXPRESSION WITH dsRNA
#147Compositions and methods for modulating kinase activity
#148Agents and methods for treating and preventing seborrheic keratosis
#149POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES
#150Compositions for treating heart disease by inhibiting the action of mAKAP-β
#151Interfering RNA molecules
#152Fusion protein crystal comprising a moiety
#153Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#154Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
#155Conjugated antisense compounds and their use
#156CHEMICAL SYNTHESIS
#157Interfering RNA molecules
#158Method for producing sphingoid base or sphingolipid
#159Method for producing phytosphingosine or sphinganine
#160Reduction of lipase activity in product formulations
#161Cell-based assay for determining mTOR activity
#162PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment
#163METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#164Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
#165BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#166Antisense conjugates for decreasing expression of DMPK
#167DAGRS: directed antigonists to cancer cell growth signals
#168PRKACB FUSIONS
#169ULK1 inhibitors and methods using same
#170Curcumin-based compositions and methods of use thereof
#171Methods of detecting DDR2 mutations
#172Interfering RNA molecules
#173Interfering RNA molecules
#174T-cell redirecting bispecific antibodies for treatment of disease
#175Modulation of breast cancer growth by modulation of XBP1 activity
#176Ligand-directed covalent modification of protein
#177C-RAF Mutants that Confer Resistance to RAF Inhibitors
#178TERT fusions
#179NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#180Targeting DNA-PKcs and B7-H1 to treat cancer
#181DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#182IMIDAZO[4,5-C]QUINOLINES AS DNA-PK INHIBITORS
#183TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN
#184Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
#185PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS
#186INHIBITING GENE EXPRESSION WITH dsRNA
#187Xylose utilizing oleaginous yeast
#188RAF gene fusions
#189Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#190Mutant huntingtin-mediated protein dysfunction
#191T-cell redirecting bispecific antibodies for treatment of disease
#192Chimeric antigen receptor (CAR) signalling system
#193SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCER
#194Biomarker for parkinson's disease and use thereof
#195Compositions and methods to promote wound healing
#196Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1
#197Substrate-mimetic AKT inhibitor
#198METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#199RECURRENT FUSION GENES IDENTIFIED IN HIGH -GRADE SEROUS OVARIAN CARCINOMA
#200Method for assaying a protease
#201Assay for Detection of Transient Intracellular CA2+
#202NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#203METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#204Mutant NNK1 allele and its use
#205Reduction of lipase activity in product formulations
#206ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON'S DISEASE
#207Multipartite signaling proteins and uses thereof
#208COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#209Methods and Kits for Detecting Prostate Cancer Biomarkers
#210Biomarkers for Ovarian Cancer
#211ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#212Polynucleotides encoding BREX system polypeptides and methods of using same
#213Aminoisoquinoline Derivatives as Protein Kinase Inhibitors
#214Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 and their use
#215siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene
#216T-cell redirecting bispecific antibodies for treatment of disease
#217T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
#2183,5-diaminopyrazole kinase inhibitors
#219BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
#220Parthenogenic activation of human oocytes for the production of neuronal cells
#221Composition for preventing or treating autoimmune disease, comprising, as active ingredient, PINK1 protein or polynucleotide encoding same
#222MELK epitope peptides and vaccines containing the same
#223Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#224Selective Sensitization of Cancer Cells to, and Selective Protection of Non-Cancer Cells from Genotoxic Therapies
#225Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#226Genetically engineered and acid-resistant yeast cell with enhanced activity of radiation sensitivity complementing kinase and method of producing lactate by using the yeast cell
#227FUSION POLYNUCLEOTIDES AND FUSION POLYPEPTIDES ASSOCIATED WITH CANCER AND PARTICULARLY MELANOMA AND THEIR USES AS THERAPEUTIC AND DIAGNOSTIC TARGETS
#228MK2 inhibitors and uses thereof
#229Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
#230MELK regulation for the treatment of breast cancer
#231Drug delivery means
#232Methods of modulating immune responses by modifying Akt3 bioactivity
#233PLANTS WITH ALTERED ROOT ARCHITECTURE, RELATED CONSTRUCTS AND METHODS INVOLVING GENES ENCODING LEUCINE RICH REPEAT KINASE (LLRK) POLYPEPTIDES AND HOMOLOGS THEREOF
#234Inhibition of histone methyltransferase for cardiac reprogramming
#235COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#236IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#237Therapeutics with conformationally restricted monomers
#238Multipartite signaling proteins and uses thereof
#239Peptide directed protein knockdown
#240PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME
#241Targets in multiple myeloma and other disorders
#242Methods and tools for identification of RSK/MSK kinase inhibitors
#243MELANOCORTIN RECEPTOR MUTANT MOUSE AND USES THEREOF
#244Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
#245Over-expression of GCN2-Type Protein Kinase in Plants
#246Animal model for epilepsy and method for producing the same
#247Compositions and methods for inducing myoblast differentiation and myotube formation
#248C-RAF mutants that confer resistance to RAF inhibitors
#249Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage
#250LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#251Rational design of microRNA-siRNA chimeras for multi-functional target suppression
#252Compositions and methods related to protein displacement therapy for myotonic distrophy
#253Agents and methods for treating and preventing seborrheic keratosis
#254Neurofibromatoses therapeutic agents and screening for same
#255Brain somatic mutations associated to epilepsy and uses thereof
#256Antisense conjugates for decreasing expression of DMPK
#257Assays for detecting modified compounds
#258Substrate-mimetic Akt inhibitor
#259Recombinant PRPK-TPRKB and uses thereof
#260INCREASED PRODUCTION OF SECRETED PROTEINS BY RECOMBINANT EUKARYOTIC CELLS
#261Genetic alterations in glioma
#262Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#263Gene delivery vehicles in the treatment of neurodegenerative diseases
#264Compositions and methods for treating cancer
#265Proteins that efficiently generate singlet oxygen
#266Glycogen synthase kinase-3 inhibitors
#267Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
#268NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#269Assay for detection of transient intracellular Ca
#270ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#271METHODS OF SUPPRESSING CANCER, INCREASING WEIGHT LOSS AND/OR INCREASING INSULIN SENSITIVITY
#272Inhibition of activated cdc42-associated kinase 1
#273Compositions and Methods for Modulation of Bone Density and Biomineralization
#274Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension
#275COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#276Pyrimidine substituted purine compounds as kinase (S) inhibitors
#277RAF gene fusions
#278Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (LLRK) polypeptides and homologs thereof
#279NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#280Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
#281METHODS AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
#282Assays for detecting modified compounds
#283Methods for expansion of hematopoietic stem and progenitor cells
#284LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#285Methods and compositions for inhibiting the proliferation of cancer cells
#286INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR
#287MELK epitope peptides and vaccines containing the same
#288Methods and compositions for generating bioactive assemblies of increased complexity and uses
#289Interfering RNA molecules
#290Methods of chemotype evolution
#291Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof
#292PTTG1 as a biomarker for cancer treatment
#293Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy
#294ANTIVIRAL INHIBITION OF CASEIN KINASE II
#295Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#296Truncated variant of the mammalian target for rapamycin (MTOR) protein
#297Assay for detection of transient intracellular CA
#298Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#299Increased production of secreted proteins by recombinant eukaryotic cells
#300COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY